Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties-Reference-Cited by-同舟云学术

Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties

Published:2022-04-27 Issue:8 Volume:14 Page:3365-3386
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

McCubrey James A.¹,Meher Akshaya K.¹,Akula Shaw M.¹,Abrams Stephen L.¹,Steelman Linda S.¹,LaHair Michelle M.¹,Franklin Richard A.¹,Martelli Alberto M.²,Ratti Stefano²,Cocco Lucio²,Barbaro Fulvio³,Duda Przemysław⁴,Gizak Agnieszka⁴

Affiliation:

1. Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA

2. Department of Biomedical and Neuromotor Sciences, Università di Bologna, Bologna, Italy

3. Department of Medicine and Surgery, Re.Mo.Bio.S. Laboratory, Anatomy Section, University of Parma, Parma, Italy

4. Department of Molecular Physiology and Neurobiology, University of Wroclaw, Wroclaw, Poland

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference101 articles.

1. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors.;Gaduputi;World J Oncol,2019

2. Cancer statistics, 2013.;Jemal;CA Cancer J Clin,2013

3. Addressing the challenges of pancreatic cancer: future directions for improving outcomes.;Heinemann;Pancreatology,2015

4. Pancreatic cancer stem cells: association with cell surface markers, prognosis, resistance, metastasis and treatment.;McCubrey;Adv Biol Regul,2014

5. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.;McCain;World J Gastroenterol,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer;Current Issues in Molecular Biology;2024-03-23

2. Ultrasound-targeted microbubble destruction improves the suppression and magnetic resonance imaging of pancreatic cancer with polyethyleneimine nanogels;Journal of Cancer;2024

3. Antitumor Drugs Targeting Mutant p53 Protein;PROG BIOCHEM BIOPHYS;2024

4. Bioengineering Approaches for the Pancreatic Tumor Organoids Research and Application;Advanced Healthcare Materials;2023-09-19

5. The role of metabolic reprogramming in pancreatic cancer chemoresistance;Frontiers in Pharmacology;2023-01-09